Cargando…
BacMam virus-based surface display for HCV E2 glycoprotein induces strong cross-neutralizing antibodies and cellular immune responses in vaccinated mice
BACKGROUND: Despite recent advancements, limitations in the treatment and control of hepatitis C virus (HCV) infection reprioritized the studies for invention of an efficient HCV vaccine to elicit strong neutralizing antibodies (NAbs) and cellular responses. METHODS: Herein, we report molecular cons...
Autores principales: | Kord, Ebrahim, Roohvand, Farzin, Dubuisson, Jean, Vausselin, Thibaut, Nasr Azadani, Hosein, Keshavarz, Abolfazl, Nejati, Ahmad, Samimi-Rad, Katayoun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684228/ https://www.ncbi.nlm.nih.gov/pubmed/34922563 http://dx.doi.org/10.1186/s13027-021-00407-x |
Ejemplares similares
-
Development of BacMam Induced Hepatitis E Virus Replication Model in Hepatoma Cells to Study the Polyprotein Processing
por: Kumar, Manjeet, et al.
Publicado: (2020) -
Transduction of HEK293 Cells with BacMam Baculovirus Is an Efficient System for the Production of HIV-1 Virus-like Particles
por: Puente-Massaguer, Eduard, et al.
Publicado: (2022) -
BacMam Virus Transduced Cardiomyoblasts Can Be Used for Myocardial Transplantation Using AP-PEG-A Microcapsules: Molecular Cloning, Preparation, and In Vitro Analysis
por: Paul, Arghya, et al.
Publicado: (2010) -
HCV Core/NS3 Protein Immunization with “N-Terminal Heat Shock gp96 Protein (rNT (gp96))” Induced Strong and Sustained Th1-Type Cytokines in Immunized Mice
por: Hajikhezri, Zamaneh, et al.
Publicado: (2021) -
Safety and Efficacy of Avaren-Fc Lectibody Targeting HCV High-Mannose Glycans in a Human Liver Chimeric Mouse Model
por: Dent, Matthew, et al.
Publicado: (2020)